Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Robert Breeze to Brain Tissue Transplantation

This is a "connection" page, showing publications Robert Breeze has written about Brain Tissue Transplantation.

 
Connection Strength
 
 
 
0.476
 
  1. Freed CR, Leehey MA, Zawada M, Bjugstad K, Thompson L, Breeze RE. Do patients with Parkinson's disease benefit from embryonic dopamine cell transplantation? J Neurol. 2003 Oct; 250 Suppl 3:III44-6.
    View in: PubMed
    Score: 0.215
  2. Gordon PH, Yu Q, Qualls C, Winfield H, Dillon S, Greene PE, Fahn S, Breeze RE, Freed CR, Pullman SL. Reaction time and movement time after embryonic cell implantation in Parkinson disease. Arch Neurol. 2004 Jun; 61(6):858-61.
    View in: PubMed
    Score: 0.056
  3. Bj?rklund A, Dunnett SB, Brundin P, Stoessl AJ, Freed CR, Breeze RE, Levivier M, Peschanski M, Studer L, Barker R. Neural transplantation for the treatment of Parkinson's disease. Lancet Neurol. 2003 Jul; 2(7):437-45.
    View in: PubMed
    Score: 0.053
  4. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med. 2001 Mar 08; 344(10):710-9.
    View in: PubMed
    Score: 0.045
  5. Freed CR, Breeze RE, Schneck SA. Transplantation of fetal mesencephalic tissue in Parkinson's disease. N Engl J Med. 1995 Sep 14; 333(11):730-1.
    View in: PubMed
    Score: 0.031
  6. Ansari AA, Mayne A, Freed CR, Breeze RE, Schneck SA, O'Brien CF, Kriek EH, Zhang YB, Mazziotta JC, Hutchinson M, et al. Lack of a detectable systemic humoral/cellular allogeneic response in human and nonhuman primate recipients of embryonic mesencephalic allografts for the therapy of Parkinson's disease. Transplant Proc. 1995 Feb; 27(1):1401-5.
    View in: PubMed
    Score: 0.030
  7. Freed CR, Breeze RE, Rosenberg NL, Schneck SA. Embryonic dopamine cell implants as a treatment for the second phase of Parkinson's disease. Replacing failed nerve terminals. Adv Neurol. 1993; 60:721-8.
    View in: PubMed
    Score: 0.026
  8. Freed CR, Breeze RE, Rosenberg NL, Schneck SA, Wells TH, Barrett JN, Grafton ST, Mazziotta JC, Eidelberg D, Rottenberg DA. Therapeutic effects of human fetal dopamine cells transplanted in a patient with Parkinson's disease. Prog Brain Res. 1990; 82:715-21.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)